Ionis Pharmaceuticals (IONS) PT Raised to $33 at Stifel on Q1 Results
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $33.00 (from $31.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
